Publications by authors named "Beatriz Moiraghi"

15Publications

Platelet Toll-Like Receptors Mediate Thromboinflammatory Responses in Patients With Essential Thrombocythemia.

Authors:
Cecilia P Marín Oyarzún Ana C Glembotsky Nora P Goette Paola R Lev Geraldine De Luca María C Baroni Pietto Beatriz Moiraghi Miguel A Castro Ríos Angeles Vicente Rosana F Marta Mirta Schattner Paula G Heller

Front Immunol 2020 30;11:705. Epub 2020 Apr 30.

Institute of Medical Research A. Lanari, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina.

View Article and Find Full Text PDF
April 2020

Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study.

Authors:
Jean-Jacques Kiladjian Pierre Zachee Masayuki Hino Fabrizio Pane Tamas Masszi Claire N Harrison Ruben Mesa Carole B Miller Francesco Passamonti Simon Durrant Martin Griesshammer Keita Kirito Carlos Besses Beatriz Moiraghi Elisa Rumi Vittorio Rosti Igor Wolfgang Blau Nathalie Francillard Tuochuan Dong Monika Wroclawska Alessandro M Vannucchi Srdan Verstovsek

Lancet Haematol 2020 Mar 23;7(3):e226-e237. Epub 2020 Jan 23.

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
March 2020

Evaluation of the primitive fraction by functional assays at the RNA and DNA level represents a novel tool for complementing molecular monitoring in chronic myeloid leukemia.

Authors:
María Sol Ruiz María Belén Sanchez Leandro Gutiérrez Daniel Koile Patricio Yankilevich Celeste Mosqueira Santiago Cranco María Del Rosario Custidiano Josefina Freitas Cecilia Foncuberta Beatriz Moiraghi Carolina Pavlovsky Mariel Ana Pérez Verónica Ventriglia Julio Sanchez Ávalos José Mordoh Irene Larripa Michele Bianchini

Oncotarget 2018 Apr 17;9(29):20255-20264. Epub 2018 Apr 17.

Centro de Investigaciones Oncológicas-Fundación Cáncer (CIO-FUCA), Ciudad Autónoma de Buenos Aires, Argentina.

View Article and Find Full Text PDF
April 2018

Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study.

Authors:
François-Xavier Mahon Carla Boquimpani Dong-Wook Kim Noam Benyamini Nelma Cristina D Clementino Vasily Shuvaev Sikander Ailawadhi Jeffrey Howard Lipton Anna G Turkina Raquel De Paz Beatriz Moiraghi Franck E Nicolini Jolanta Dengler Tomasz Sacha Naoto Takahashi Rafik Fellague-Chebra Sandip Acharya Stephane Wong Yu Jin Timothy P Hughes

Ann Intern Med 2018 04 20;168(7):461-470. Epub 2018 Feb 20.

University of Adelaide, Adelaide, South Australia, Australia (T.P.H.).

View Article and Find Full Text PDF
April 2018

Neutrophil extracellular trap formation and circulating nucleosomes in patients with chronic myeloproliferative neoplasms.

Authors:
Cecilia P Marin Oyarzún Agostina Carestia Paola R Lev Ana C Glembotsky Miguel A Castro Ríos Beatriz Moiraghi Felisa C Molinas Rosana F Marta Mirta Schattner Paula G Heller

Sci Rep 2016 12 13;6:38738. Epub 2016 Dec 13.

Department of Hematology Research, Institute of Medical Research "Alfredo Lanari", University of Buenos Aires, National Council for Scientific and Technological Research (CONICET), Buenos Aires, Argentina.

View Article and Find Full Text PDF
December 2016

GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response.

Authors:
Natalia Weich Cristian Ferri Beatriz Moiraghi Raquel Bengió Isabel Giere Carolina Pavlovsky Irene B Larripa Ariela F Fundia

Cancer Epidemiol 2016 10 25;44:16-21. Epub 2016 Jul 25.

Laboratorio de Genética Hematológica, IMEX, CONICET-Academia Nacional de Medicina, Buenos Aires, Argentina. Electronic address:

View Article and Find Full Text PDF
October 2016

TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome.

Authors:
Natalia Weich Cristian Ferri Beatriz Moiraghi Raquel Bengió Isabel Giere Carolina Pavlovsky Irene Larripa Ariela Fundia

Blood Cells Mol Dis 2016 07 11;59:129-33. Epub 2016 May 11.

Laboratorio de Genética Hematológica, IMEX, CONICET-Academia Nacional de Medicina, Buenos Aires, Argentina. Electronic address:

View Article and Find Full Text PDF
July 2016

Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial.

Authors:
Srdan Verstovsek Alessandro M Vannucchi Martin Griesshammer Tamas Masszi Simon Durrant Francesco Passamonti Claire N Harrison Fabrizio Pane Pierre Zachee Keita Kirito Carlos Besses Masayuki Hino Beatriz Moiraghi Carole B Miller Mario Cazzola Vittorio Rosti Igor Blau Ruben Mesa Mark M Jones Huiling Zhen Jingjin Li Nathalie Francillard Dany Habr Jean-Jacques Kiladjian

Haematologica 2016 07 21;101(7):821-9. Epub 2016 Apr 21.

Centre d'Investigations Cliniques (INSERM CIC 1427), Hôpital Saint-Louis and Université Paris Diderot, Paris, France.

View Article and Find Full Text PDF
July 2016

MDR1/ABCB1 gene polymorphisms in patients with chronic myeloid leukemia.

Authors:
Mabel Lardo Marcelo Castro Beatriz Moiraghi Francisca Rojas Natalia Borda Jorge A Rey Alberto Lazarowski

Blood Res 2015 Sep 22;50(3):154-9. Epub 2015 Sep 22.

INFIBIOC-FFyB-UBA, Buenos Aires, Argentina. ; Fundación Investigar, Buenos Aires, Argentina.

View Article and Find Full Text PDF
September 2015

Clinical outcome of chronic myeloid leukemia imatinib-resistant patients: do BCR-ABL kinase domain mutations affect patient survival? First multicenter Argentinean study.

Authors:
Raquel M Bengió Maria E Riva Beatriz Moiraghi Emilio Lanari Jorge Milone Veronica Ventriglia Eduardo Bullorsky Miguel de Tezanos Pinto Hector Murro Michele Bianchini Irene Larripa

Leuk Lymphoma 2011 Sep 12;52(9):1720-6. Epub 2011 Jun 12.

Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Buenos Aires, Argentina.

View Article and Find Full Text PDF
September 2011

Molecular monitoring of imatinib in chronic myeloid leukemia patients in complete cytogenetic remission: does achievement of a stable major molecular response at any time point identify a privileged group of patients? A multicenter experience in Argentina and Uruguay.

Authors:
Carolina Pavlovsky Isabel Giere Beatriz Moiraghi Miguel A Pavlovsky Pedro Negri Aranguren Juan García Isolda Fernandez Raquel Bengió Jorge Milone Valentin Labanca Rosario Uriarte Virginia Lombardi Fernanda García Reinoso Alicia E Magariños Lem Martinez Héctor Murro Francisco Lastiri Santiago Pavlovsky

Clin Lymphoma Myeloma Leuk 2011 Jun 20;11(3):280-5. Epub 2011 Apr 20.

FUNDALEU, Centro de Internación e Investigación Clínica Angélica Ocampo, Buenos Aires, Argentina.

View Article and Find Full Text PDF
June 2011

BAX/BCL-XL gene expression ratio inversely correlates with disease progression in chronic myeloid leukemia.

Authors:
Mariana S Gonzalez Carlos D De Brasi Michele Bianchini Patricia Gargallo Beatriz Moiraghi Raquel Bengió Irene B Larripa

Blood Cells Mol Dis 2010 Oct 21;45(3):192-6. Epub 2010 Aug 21.

Instituto de Investigaciones Hematológicas Mariano R. Castex, Academia Nacional de Medicina de Buenos Aires, Argentina.

View Article and Find Full Text PDF
October 2010

Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia.

Authors:
Hagop Kantarjian Neil P Shah Andreas Hochhaus Jorge Cortes Sandip Shah Manuel Ayala Beatriz Moiraghi Zhixiang Shen Jiri Mayer Ricardo Pasquini Hirohisa Nakamae Françoise Huguet Concepción Boqué Charles Chuah Eric Bleickardt M Brigid Bradley-Garelik Chao Zhu Ted Szatrowski David Shapiro Michele Baccarani

N Engl J Med 2010 Jun 5;362(24):2260-70. Epub 2010 Jun 5.

Department of Leukemia, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

View Article and Find Full Text PDF
June 2010

Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: tyrosine kinase inhibitor optimization and selectivity study.

Authors:
Jorge E Cortes Michele Baccarani François Guilhot Brian J Druker Susan Branford Dong-Wook Kim Fabrizio Pane Ricardo Pasquini Stuart L Goldberg Matt Kalaycio Beatriz Moiraghi Jacob M Rowe Elena Tothova Carmino De Souza Marc Rudoltz Richard Yu Tillmann Krahnke Hagop M Kantarjian Jerald P Radich Timothy P Hughes

J Clin Oncol 2010 Jan 14;28(3):424-30. Epub 2009 Dec 14.

University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article and Find Full Text PDF
January 2010

Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders.

Authors:
Ana L Basquiera Néstor W Soria Ricardo Ryser Miriam Salguero Beatriz Moiraghi Federico Sackmann Ana G Sturich Adriana Borello Adriana Berretta Miriam Bonafé José Moreno Barral Emilio D Palazzo Juan J García

Hematology 2009 Dec;14(6):323-30

Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina.

View Article and Find Full Text PDF
December 2009